| dbo:abstract |
سرطانة الرئة غير صغيرة الخلايا (NSCLC) هو أي نمط من سرطان الخلايا الرئوية الظهارية دون سرطانة الرئة صغيرة الخلايا (SCLC). يُسجّل (NSCLC) نسبة 85% من إجمالي حالات سرطان الرئة. كتصنيف، تكون سرطانة الرئة غير صغيرة الخلايا غير حساسة نسبيًا للعلاج الكيميائي مقارنةً بسرطانة الرئة صغيرة الخلايا. عند الإمكان، يُعالج (NSCLC) جراحيًا بالتداخل الجراحي، بالرغم من تزايد استخدام العلاج الكيميائي قبل العمل الجراحي (العلاج الكيميائي المساعد الجديد) وبعد العمل الجراحي (العلاج الكيميائي المساعد). (ar) El carcinoma pulmonar no microcítico (CPNM), también denominado cáncer pulmonar de células no pequeñas, (en idioma inglés: Non Small-Cell Lung Cancer (NSCLC)), es un tipo de cáncer de pulmón. Junto con el carcinoma pulmonar microcítico, son los dos grandes grupos de clasificación que resultan del estudio de las características de las células de las cuales deriva esta enfermedad. Los carcinomas no microcíticos son el tipo más común de cánceres de pulmón y a su vez, pueden distinguirse en tres subtipos: * Carcinoma escamoso o epidermoide: Es la variedad más frecuente y tiende a localizarse en la parte central de los pulmones, presentando un crecimiento relativamente lento. * Adenocarcinoma: A diferencia del carcino epidermoide, suele localizarse en zonas más periféricas de los pulmones, por lo que frecuentemente afectan a otros tejidos como la pleura y la pared torácica. * Carcinoma de células grandes: Es el tipo menos frecuente de los carcinomas broncopulmonares, recibiendo este nombre por el tamaño de las células afectadas. (es) Les cancers bronchiques non à petites cellules sont un type de cancers du poumon, généralement traité par chirurgie (lobectomie pulmonaire ou pneumonectomie) ou radiothérapie et chimiothérapie. Les cancers non à petites cellules sont regroupés parce que leur pronostic et leur traitement sont semblables. L'acronyme CBNPC est utilisé dans le langage médical. (fr) Non-small-cell lung cancer (NSCLC) is any type of epithelial lung cancer other than small-cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell carcinoma. When possible, they are primarily treated by surgical resection with curative intent, although chemotherapy has been used increasingly both preoperatively (neoadjuvant chemotherapy) and postoperatively (adjuvant chemotherapy). (en) 비소세포폐암(非小細胞肺癌)은 폐암의 일종이다. (ko) Icke-småcellig lungcancer (NSCLC), även icke-småcelligt lungcarcinom, är ett samlingsnamn för de former av epiteliala lungcancrar som ej ingår i kategorin småcelligt lungcarcinom. NSCLC står för cirka 85% av alla lungcancrar. Som kategori är icke-småcellig lungcancer relativt okänslig för kemoterapi, jämfört med småcelliga lungcarcinom. Kurativt syftande kirurgisk resektion är, när möjligt, den primära behandlingsmodaliteten. I allt högre grad används numera kemoterapi både pre-operativt och post-operativt. (sv) O carcinoma de pulmão não pequenas células (CNPC) é qualquer tipo de câncer de pulmão epitelial, exceto os carcinomas de pequenas células (CPC). É assim, um diagnóstico de exclusão (ou seja, um diagnóstico feito a partir da exclusão de outras possibilidades para melhorar a eficácia terapêutica quando não é produtivo e necessário fazer um diagnóstico mais preciso) que funciona similar ao Linfoma não Hodgkin (incluem todos linfomas, menos o linfoma de Hodgkin) e ao câncer de pele não-melanoma (inclui todos cânceres de pele menos, o melanoma). (pt) |
| dbo:eMedicineSubject |
med (en) |
| dbo:eMedicineTopic |
1333 (en) |
| dbo:icd10 |
C34.90 |
| dbo:icd9 |
162 |
| dbo:medlinePlus |
007194 |
| dbo:meshId |
D002289 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Squamous_carcinoma_lung_cytology.gif?width=300 |
| dbo:wikiPageExternalLink |
https://doi.org/10.3390/ph13110373 https://doi.org/10.3390/ph13110373%7Cthumb%7CThe https://doi.org/10.3390/ph13110373%7Cthumb%7COverall |
| dbo:wikiPageID |
5955888 (xsd:integer) |
| dbo:wikiPageLength |
45782 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1101829030 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Carboplatin dbr:Carcinoid dbr:American_Joint_Committee_on_Cancer dbr:Epidermal_growth_factor dbr:Epidermal_growth_factor_receptor dbc:Lung_cancer dbr:Bevacizumab dbr:Biopsy dbr:Hypercalcaemia dbr:Pembrolizumab dbr:Resection_(surgery) dbr:Cytopathology dbr:DNA_methylation dbr:DNA_repair dbr:Eastern_Cooperative_Oncology_Group dbr:Radon dbr:Nurses'_Health_Study dbr:Crizotinib dbr:Cryoablation dbr:Anaplastic_lymphoma_kinase dbr:Vascular_endothelial_growth_factor dbr:MLH1 dbr:Ku80 dbr:Cisplatin dbr:Gefitinib dbr:Lung_cancer dbr:Combined_small-cell_lung_carcinoma dbr:Comorbidity dbr:Pancoast_tumor dbr:Tyrosine_kinase_inhibitor dbr:Mediastinum dbr:Micrograph dbr:Microhomology-mediated_end_joining dbr:Microwave_ablation dbr:O-6-methylguanine-DNA_methyltransferase dbr:BRAF_(gene) dbr:Bronchi dbr:Adjuvant_therapy dbr:Cetuximab dbr:Whole_genome_sequencing dbr:HER2 dbr:Adenocarcinoma dbr:Afatinib dbr:Cyberknife_(device) dbr:Erlotinib dbr:Food_and_Drug_Administration dbr:Base_excision_repair dbr:Nivolumab dbr:Osimertinib dbr:Paclitaxel dbr:Carcinogenesis dbr:BRCA1 dbr:BRCA2 dbr:Flap_structure-specific_endonuclease_1 dbr:ALK_inhibitor dbr:Chemotherapy dbr:TNM_staging_system dbr:Homologous_recombination dbr:Mobocertinib dbr:C-Met dbr:Pleura dbr:FNA_specimen dbr:Metastases dbr:Necitumumab dbr:Ataxia_telangiectasia_mutated dbr:Cancer_epigenetics dbr:Radiation_therapy dbr:Radiofrequency_ablation dbr:Lung dbr:MSH2 dbr:ROS1 dbr:Small-cell_lung_carcinoma dbr:Squamous-cell_carcinoma dbr:Tobacco_smoking dbr:Neoadjuvant_therapy dbr:Nonhomologous_end_joining dbr:Chemoembolization dbr:NEIL1 dbr:Companion_diagnostic dbr:Relative_risk dbr:PD-L1 dbr:Werner_syndrome_ATP-dependent_helicase dbr:Superior_vena_cava_syndrome dbr:International_Union_Against_Cancer dbr:Pap_stain dbr:Anaplastic dbr:Large-cell_carcinoma dbr:KRas dbr:Mismatch_repair dbr:Squamous_carcinoma dbr:File:Pie_chart_of_lung_cancers.svg dbr:Stereotactic_body_radiation_therapy dbr:File:Ca_bronchus.jpg dbr:File:PD-L1_positive_lung_adenocarcinoma_--_intermed_mag.jpg dbr:File:Monoclonal_antibodies_used_in_the...er_and_their_mechanism_of_action.webp dbr:File:Overall_survival_in_non-small_lun...or_advanced_or_metastatic_disease.jpg dbr:File:Pharmaceuticals-13-00373-g002-550.jpg |
| dbp:caption |
Micrograph of a squamous carcinoma, a type of nonsmall-cell lung carcinoma, FNA specimen, Pap stain. (en) |
| dbp:emedicinesubj |
med (en) |
| dbp:emedicinetopic |
1333 (xsd:integer) |
| dbp:icd |
162 (xsd:integer) 34.9 (dbd:nicaraguanCórdoba) |
| dbp:medlineplus |
7194 (xsd:integer) |
| dbp:meshid |
D002289 (en) |
| dbp:name |
Nonsmall-cell lung carcinoma (en) |
| dbp:scholia |
Q3658562 (en) |
| dbp:wikiPageUsesTemplate |
dbt:Citation_needed dbt:Cn dbt:Dubious dbt:Further dbt:Infobox_medical_condition_(new) dbt:Main dbt:Medical_resources dbt:Reflist dbt:See_also dbt:Short_description dbt:Use_dmy_dates dbt:Respiratory_and_intrathoracic_neoplasia dbt:MedlinePlusEncyclopedia |
| dct:subject |
dbc:Lung_cancer |
| rdf:type |
owl:Thing wikidata:Q12136 yago:Abstraction100002137 yago:Attribute100024264 yago:Condition113920835 yago:Disease114070360 yago:IllHealth114052046 yago:Illness114061805 yago:PathologicalState114051917 yago:PhysicalCondition114034177 dbo:Disease yago:State100024720 umbel-rc:AilmentCondition |
| rdfs:comment |
سرطانة الرئة غير صغيرة الخلايا (NSCLC) هو أي نمط من سرطان الخلايا الرئوية الظهارية دون سرطانة الرئة صغيرة الخلايا (SCLC). يُسجّل (NSCLC) نسبة 85% من إجمالي حالات سرطان الرئة. كتصنيف، تكون سرطانة الرئة غير صغيرة الخلايا غير حساسة نسبيًا للعلاج الكيميائي مقارنةً بسرطانة الرئة صغيرة الخلايا. عند الإمكان، يُعالج (NSCLC) جراحيًا بالتداخل الجراحي، بالرغم من تزايد استخدام العلاج الكيميائي قبل العمل الجراحي (العلاج الكيميائي المساعد الجديد) وبعد العمل الجراحي (العلاج الكيميائي المساعد). (ar) Les cancers bronchiques non à petites cellules sont un type de cancers du poumon, généralement traité par chirurgie (lobectomie pulmonaire ou pneumonectomie) ou radiothérapie et chimiothérapie. Les cancers non à petites cellules sont regroupés parce que leur pronostic et leur traitement sont semblables. L'acronyme CBNPC est utilisé dans le langage médical. (fr) Non-small-cell lung cancer (NSCLC) is any type of epithelial lung cancer other than small-cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell carcinoma. When possible, they are primarily treated by surgical resection with curative intent, although chemotherapy has been used increasingly both preoperatively (neoadjuvant chemotherapy) and postoperatively (adjuvant chemotherapy). (en) 비소세포폐암(非小細胞肺癌)은 폐암의 일종이다. (ko) Icke-småcellig lungcancer (NSCLC), även icke-småcelligt lungcarcinom, är ett samlingsnamn för de former av epiteliala lungcancrar som ej ingår i kategorin småcelligt lungcarcinom. NSCLC står för cirka 85% av alla lungcancrar. Som kategori är icke-småcellig lungcancer relativt okänslig för kemoterapi, jämfört med småcelliga lungcarcinom. Kurativt syftande kirurgisk resektion är, när möjligt, den primära behandlingsmodaliteten. I allt högre grad används numera kemoterapi både pre-operativt och post-operativt. (sv) O carcinoma de pulmão não pequenas células (CNPC) é qualquer tipo de câncer de pulmão epitelial, exceto os carcinomas de pequenas células (CPC). É assim, um diagnóstico de exclusão (ou seja, um diagnóstico feito a partir da exclusão de outras possibilidades para melhorar a eficácia terapêutica quando não é produtivo e necessário fazer um diagnóstico mais preciso) que funciona similar ao Linfoma não Hodgkin (incluem todos linfomas, menos o linfoma de Hodgkin) e ao câncer de pele não-melanoma (inclui todos cânceres de pele menos, o melanoma). (pt) El carcinoma pulmonar no microcítico (CPNM), también denominado cáncer pulmonar de células no pequeñas, (en idioma inglés: Non Small-Cell Lung Cancer (NSCLC)), es un tipo de cáncer de pulmón. Junto con el carcinoma pulmonar microcítico, son los dos grandes grupos de clasificación que resultan del estudio de las características de las células de las cuales deriva esta enfermedad. Los carcinomas no microcíticos son el tipo más común de cánceres de pulmón y a su vez, pueden distinguirse en tres subtipos: (es) |
| rdfs:label |
سرطانة الرئة غير صغيرة الخلايا (ar) Carcinoma pulmonar no microcítico (es) Cancer bronchique non à petites cellules (fr) 비소세포폐암 (ko) Non-small-cell lung carcinoma (en) Carcinoma de pulmão de células não pequenas (pt) Icke-småcellig lungcancer (sv) |
| rdfs:seeAlso |
dbr:Lung_cancer_surgery |
| owl:sameAs |
freebase:Non-small-cell lung carcinoma http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/3390 http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/845 wikidata:Non-small-cell lung carcinoma dbpedia-ar:Non-small-cell lung carcinoma dbpedia-bg:Non-small-cell lung carcinoma http://bs.dbpedia.org/resource/Nemikroćelijski_karcinom_pluća dbpedia-es:Non-small-cell lung carcinoma dbpedia-fr:Non-small-cell lung carcinoma dbpedia-ko:Non-small-cell lung carcinoma http://lt.dbpedia.org/resource/Nesmulkių_ląstelių_plaučių_karcinoma dbpedia-nn:Non-small-cell lung carcinoma dbpedia-pt:Non-small-cell lung carcinoma dbpedia-sh:Non-small-cell lung carcinoma dbpedia-sl:Non-small-cell lung carcinoma dbpedia-sv:Non-small-cell lung carcinoma https://global.dbpedia.org/id/3PPRd |
| skos:closeMatch |
http://www.springernature.com/scigraph/things/subjects/non-small-cell-lung-cancer |
| prov:wasDerivedFrom |
wikipedia-en:Non-small-cell_lung_carcinoma?oldid=1101829030&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Overall_survival_in_n...or_advanced_or_metastatic_disease.jpg wiki-commons:Special:FilePath/Pharmaceuticals-13-00373-g002-550.jpg wiki-commons:Special:FilePath/Pie_chart_of_lung_cancers.svg wiki-commons:Special:FilePath/Ca_bronchus.jpg wiki-commons:Special:FilePath/PD-L1_positive_lung_adenocarcinoma_--_intermed_mag.jpg wiki-commons:Special:FilePath/Squamous_carcinoma_lung_cytology.gif |
| foaf:isPrimaryTopicOf |
wikipedia-en:Non-small-cell_lung_carcinoma |
| foaf:name |
Nonsmall-cell lung carcinoma (en) |
| is dbo:wikiPageDisambiguates of |
dbr:NSCC |
| is dbo:wikiPageRedirects of |
dbr:Non-Small_Cell_Lung_Cancer dbr:Non-small-cell_lung_carcinoma_staging dbr:Non-small_cell_carcinoma dbr:Non-small_cell_lung_cancer dbr:Non-small_cell_lung_cancer_staging dbr:Non-small_cell_lung_carcinoma dbr:Non-small_cell_lung_carcinoma_staging dbr:Non-small_cell_lung_carcinomas dbr:Non_small-cell_lung_cancer dbr:Non_small_cell_lung_carcinoma dbr:Non-small-cell_lung_cancer dbr:Non_small-cell_lung_carcinoma dbr:NSCLC dbr:Squamous_cell_carcinoma_of_lung dbr:Squamous_cell_lung_cancer dbr:Carcinoma,_non-small-cell_lung |
| is dbo:wikiPageWikiLink of |
dbr:Cabozantinib dbr:Cardiothoracic_surgery dbr:BCL2L2 dbr:Quinazoline dbr:Sarcomatoid_carcinoma dbr:Epidermal_growth_factor_receptor dbr:List_of_cancer_types dbr:List_of_drugs_granted_breakthrough_therapy_designation dbr:MicroRNA dbr:NSCC dbr:Mesoblastic_nephroma dbr:Metronomic_therapy dbr:Oncogene_addiction dbr:Simcere_Pharmaceutical dbr:Non-Small_Cell_Lung_Cancer dbr:Non-small-cell_lung_carcinoma_staging dbr:Non-small_cell_carcinoma dbr:Non-small_cell_lung_cancer dbr:Non-small_cell_lung_cancer_staging dbr:Non-small_cell_lung_carcinoma dbr:Non-small_cell_lung_carcinoma_staging dbr:Non-small_cell_lung_carcinomas dbr:Non_small-cell_lung_cancer dbr:Non_small_cell_lung_carcinoma dbr:Bevacizumab dbr:DNA_glycosylase dbr:DNA_methylation_in_cancer dbr:CDC20 dbr:Vintafolide dbr:Viralytics dbr:Vorinostat dbr:Downregulation_and_upregulation dbr:GLRX2 dbr:Medarex dbr:Chemotherapy-induced_peripheral_neuropathy dbr:NUMB_(gene) dbr:Nanomedicine dbr:Proteasome_(prosome,_macropain)_subunit,_alpha_1 dbr:Targeted_molecular_therapy_for_neuroblastoma dbr:Ku80 dbr:Giant-cell_carcinoma_of_the_lung dbr:NAMI-A dbr:Damage-associated_molecular_pattern dbr:Laboratory_Syrian_hamster dbr:TIGIT dbr:Anne_Francis dbr:Lung_cancer dbr:Calotropis_gigantea dbr:Small-cell_carcinoma dbr:Derlin-1 dbr:Monoclonal_antibody_therapy dbr:Pancoast_tumor dbr:Tumor_mutational_burden dbr:BRAF_(gene) dbr:Bristol_Myers_Squibb dbr:C-Met_inhibitor dbr:Adenocarcinoma_of_the_lung dbr:Tivantinib dbr:GATA2 dbr:HIF1A dbr:HOXA11-AS1 dbr:HPG80 dbr:Large-cell_lung_carcinoma_with_rhabdoid_phenotype dbr:Large_cell_neuroendocrine_carcinoma_of_the_lung dbr:Lasers_in_cancer_treatment dbr:Laura_Soucek dbr:Topoisomerase_inhibitor dbr:Abemaciclib dbr:Amgen dbr:Anamorelin dbr:Dacomitinib dbr:Edelfosine dbr:Farletuzumab dbr:Base_excision_repair dbr:Osimertinib dbr:Paclitaxel dbr:Palbociclib dbr:Carcinoembryonic_antigen_peptide-1 dbr:Causes_of_cancer_pain dbr:CimaVax-EGF dbr:Digital_polymerase_chain_reaction dbr:Kinase_insert_domain_receptor dbr:Halozyme dbr:CpG_site dbr:Atezolizumab dbr:Large-cell_lung_carcinoma dbr:Blocking_antibody dbr:Collagen,_type_XXIII,_alpha_1 dbr:Eftilagimod_alpha dbr:Tafazzin dbr:Mitochondrial_dicarboxylate_carrier dbr:Mobocertinib dbr:Regulation_of_transcription_in_cancer dbr:Dicycloplatin dbr:Dostarlimab dbr:BI_811283 dbr:CASS4 dbr:CKLF-like_MARVEL_transmembrane_domain-containing_5 dbr:CKLF_like_MARVEL_transmembrane_domain-containing_8 dbr:CRTC2 dbr:Sotorasib dbr:Fibroblast_growth_factor_receptor_1 dbr:USP27X dbr:Interferon_type_II dbr:Necitumumab dbr:Cancer_biomarker dbr:Cancer_vaccine_targeting_CD4+_T_cells dbr:Ramucirumab dbr:Sean_Lock dbr:Christine_Lovly dbr:Long_non-coding_RNA dbr:Lung dbr:MARCO dbr:MSH2 dbr:UGT2B7 dbr:Non-small-cell_lung_cancer dbr:Non_small-cell_lung_carcinoma dbr:VEGFR1 dbr:List_of_therapeutic_monoclonal_antibodies dbr:Lung_cancer_in_Australia dbr:Lungscape dbr:Tumor_microenvironment dbr:Malignant_transformation dbr:NCI-60 dbr:NEIL1 dbr:Squamous-cell_carcinoma_of_the_lung dbr:NSCLC dbr:Multimodal_cancer_therapy dbr:M0 dbr:XRCC1 dbr:Peptidomimetic dbr:Personalized_genomics dbr:Personalized_onco-genomics dbr:Oxoguanine_glycosylase dbr:PARAMOUNT_trial dbr:PD-1_and_PD-L1_inhibitors dbr:Synthetic_lethality dbr:TRPV6 dbr:SNAP47 dbr:Squamous_cell_carcinoma_of_lung dbr:Squamous_cell_lung_cancer dbr:Carcinoma,_non-small-cell_lung |
| is dbp:types of |
dbr:Lung_cancer |
| is foaf:primaryTopic of |
wikipedia-en:Non-small-cell_lung_carcinoma |
